Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126571) titled 'A Prospective Phase II Study Exploring the Effective Combination of Induction Therapy, Concurrent Chemoradiotherapy, and Consolidation Therapy for Organ Preservation in Esophageal Cancer' on June 11.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
Condition:
Esophageal carcinoma
Intervention:
Group A:Inductive chemotherapy, chemoradiation, and 2 cycles of consolidion chemotherapy
Group B:Inductive chemotherapy, chemoradiation, and 4 cycles of consolidion chemotherapy
Recruitment Status: Not Recruiting
Phase: N/A...